WeVote

Bill

Bill

HB 156

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE HEALTHCARE ASSOCIATED INFECTIONS DISCLOSURE ACT.

153rd General Assembly (2025-2026) Introduced by Frank Burns and 3 co-sponsors

Delaware law amended to modify healthcare facility reporting requirements for hospital-acquired infections, affecting patient transparency and infection control accountability standards.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 156

Legislative bill overview

HB 156 amends Delaware's Healthcare Associated Infections Disclosure Act, which requires hospitals and healthcare facilities to publicly report infections acquired during patient care. The bill modifies existing disclosure requirements, reporting timelines, or transparency standards for healthcare-associated infections (HAIs).

Why is this important

Healthcare-associated infections affect approximately 1 in 31 hospitalized patients nationally and increase mortality, complications, and healthcare costs. Transparent reporting enables patients to make informed care decisions, allows regulators to identify systemic problems, and creates accountability pressure for facilities to improve infection control practices.

Potential points of contention

  • Scope of reporting requirements – May expand or contract which facilities must report and which infections must be disclosed, affecting regulatory burden on providers versus public access to information
  • Reporting timelines and data lag – Changes to when infections must be reported could affect data timeliness versus facility administrative feasibility
  • Competitive disadvantage concerns – Healthcare providers may worry public disclosure of infection rates damages reputation and competitiveness, even if rates reflect broader industry patterns

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.